<DOC>
	<DOCNO>NCT02943590</DOCNO>
	<brief_summary>This research study test whether atorvastatin , drug commonly prescribe reduce cholesterol level , protect heart chemotherapy doxorubicin . Atorvastatin family medication commonly call `` statin ''</brief_summary>
	<brief_title>STOP-CA ( Statins TO Prevent Cardiotoxicity From Anthracyclines )</brief_title>
	<detailed_description>This research study Phase II clinical trial . Phase II clinical trial test effectiveness drug determine whether investigational drug work treat specific disease . `` Investigational '' mean drug study . The chemotherapy drug participant schedule treat , Doxorubicin , associate development heart failure patient . This research study test whether Atorvastatin protect heart patient treat Doxorubicin reduce cardiac injury risk heart failure . Atorvastatin approve FDA ( U.S. Food Drug Administration ) use reduce cardiac injury Doxorubicin . Atorvastatin approve FDA lower cholesterol reduce risk heart attack stroke . The heart muscle pump blood Atorvastatin may protect heart preserve cardiac muscle function . The investigator test whether atorvastatin protects heart use combination image test participant heart , blood test , stress testing . The imaging test involve echocardiogram ( echo ) cardiac magnetic resonance ( CMR ) , type magnetic resonance imaging ( MRI ) scan .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiotoxicity</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>&gt; 18 year age All patient newly diagnose NHL Scheduled receive anthracyclinebased therapy CHOP/RCHOP type Statin use Statin use indicate base guideline Pregnancy breastfeed Unable provide inform consent Unexplained persistent elevation transaminase ( &gt; 3 time upper limit normal ) Concomitant use cyclosporine Renal failure : estimate glomerular filtration &lt; 45 mL/min/1.73 m2 Contraindication CMR ( metallic object , severe claustrophobia , pacemaker , vascular clip LVEF &lt; 50 % baseline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cancer Treatment Related Heart Failure</keyword>
</DOC>